Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer-Reference-Cited by-同舟云学术

Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer

Published:2016-05-18 Issue:15 Volume:122 Page:2341-2349
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Falchook Aaron D.¹,Basak Ramsankar¹,Mohiuddin Jahan J.¹,Chen Ronald C.¹²

Affiliation:

1. Department of Radiation Oncology; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

2. University of North Carolina Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D'Amico;JAMA.,2008

2. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial;Denham;Lancet Oncol.,2005

3. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610;Roach;J Clin Oncol.,2008

4. National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology: prostate cancer. Version 1.2015 http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf 2014

5. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med.,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer;Radiotherapy and Oncology;2023-06

2. Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy;Advances in Radiation Oncology;2022-07

3. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis;The Lancet Oncology;2022-02

4. Optimizing androgen deprivation therapy with radiation therapy for aggressive localized and locally advanced prostate cancer;Urologic Oncology: Seminars and Original Investigations;2021-10

5. Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study;European Urology Focus;2021-03